Latest News

SS Innovations International (SSII) drew investor attention after releasing its 2025 results, which combined higher reported revenue with a smaller annual net loss and, at the same time, a going concern warning from auditor BDO LLP. See our latest analysis for SS Innovations International. At a share price of US$5.01, SS Innovations International has seen a 25% 1 month share price return, while the year to date share price return and 1 year total shareholder return remain negative. This hints...

Now profitable: Eva Live reported 82.6% revenue growth to $17M for FY2025 and swung to $8.1M net income, compared to a loss in 2024.

Tantalus Systems Holding (TSX:GRID) has rounded out FY 2025 with fourth quarter revenue of US$14.9 million and basic EPS of US$0.003, while trailing 12 month figures show revenue of US$54.1 million and a basic EPS loss of US$0.019. Over recent quarters the company has seen revenue move from US$11.9 million in Q1 2025 to US$14.9 million in Q4 2025, with quarterly EPS ranging between a loss of US$0.018 in Q2 and a profit of US$0.007 in Q3. This has left investors focused on how quickly margins...

FY 2025 earnings snapshot for Alvotech (NasdaqGM:ALVO) Alvotech (NasdaqGM:ALVO) closed FY 2025 with Q4 revenue of US$168.9 million and a basic EPS loss of US$0.44, as net income excluding extra items came in at a loss of US$108.5 million. The company has seen quarterly revenue range from US$102.99 million in Q3 2024 to US$173.3 million in Q2 2025, while basic EPS has swung between a loss of US$0.23 in Q4 2024 and a profit of US$0.39 in Q1 2025. This sets up a year where the trailing twelve...

Vonovia (XTRA:VNA) closed out FY 2025 with fourth quarter revenue of €1,533.2 million and basic EPS of €0.69, setting the tone for how investors will read the year in full. Over recent periods, revenue moved from €2,297.1 million in Q4 2024 to €1,533.2 million in Q4 2025, while quarterly EPS shifted from a loss of €0.48 per share in Q4 2024 to a profit of €0.69 per share in Q4 2025, with trailing twelve month EPS at €4.38. With earnings forecast to grow around 7.7% per year even as revenue is...

Strive Asset Management (ASST) FY 2025 earnings snapshot Strive Asset Management (ASST) has just wrapped up FY 2025 with Q4 total revenue of about US$1.3 million and a loss per share of US$6.17, alongside a net loss excluding extra items of US$205.6 million, setting a stark backdrop for the latest numbers. Over the past year, revenue has moved from roughly US$0.8 million in Q2 2024 to US$1.3 million in Q4 2025, while trailing twelve month EPS shifted from a US$194.99 loss to a US$12.74 loss...

HomeToGo (XTRA:HTG) just wrapped up FY 2025 with fourth quarter revenue of €54.2 million and a net loss of €88.5 million, capping a year in which trailing twelve month revenue reached €255.5 million and the trailing loss came to €100.0 million. Over recent periods, quarterly revenue has ranged from €34.4 million in Q1 2025 to €108.1 million in Q3 2025, while quarterly net results have swung between a loss of €38.5 million in Q1 and a profit of €31.1 million in Q3. This sets up a results...

Tejon Ranch (TRC) has just wrapped up FY 2025 with fourth quarter revenue of US$21.1 million and basic EPS of US$0.06, while the full year on a trailing 12 month basis came in at US$49.6 million of revenue and essentially breakeven EPS around US$0.00. Over recent quarters, the company has seen revenue move from US$8.3 million and basic EPS of a US$0.06 loss in Q2 2025 to US$11.0 million and a US$0.06 loss in Q3 2024, before reaching Q4 2025’s US$21.1 million and US$0.06 EPS. This sets up a...

Accenture (ACN) has reported Q2 2026 results with revenue of US$18.0b and basic EPS of US$2.96, setting the tone for how its consulting and technology services engine is currently translating into top and bottom line performance. The company has seen quarterly revenue move from US$16.7b in Q2 2025 to US$18.0b in Q2 2026, while basic EPS over the same quarters has shifted from US$2.85 to US$2.96, giving investors a clear read on how sales and earnings are tracking together. With a trailing net...

A class action lawsuit has been filed against Soleno Therapeutics (NasdaqCM:SLNO) alleging failures to disclose significant safety concerns in clinical trials for its drug DCCR. The complaint targets the company and certain executives, claiming that undisclosed issues could affect DCCR's commercial prospects and Soleno's reputation. The case focuses on the period around the development and launch preparations of DCCR, Soleno's sole commercial product. Soleno Therapeutics is a biotech...

Aveanna Healthcare Holdings (AVAH) delivers full year 2025 results Aveanna Healthcare Holdings (AVAH) has wrapped up FY 2025 with fourth quarter revenue of US$662.5 million, basic EPS of US$0.85 and net income excluding extraordinary items of US$178.8 million. This frames a year where trailing twelve month revenue reached about US$2.4 billion and basic EPS was US$1.11. Over recent periods the company has seen revenue move from US$519.9 million in Q4 FY 2024 to US$662.5 million in Q4 FY 2025,...

Swatch Group (SWX:UHR) has delivered a soft set of FY 2025 numbers, with second half revenue of CHF 3.2b and net income excluding extra items of essentially break even, alongside a current share price of CHF 164.45. The company has seen half year revenue move from CHF 3.3b in second half 2024 to CHF 3.1b in first half 2025 and CHF 3.2b in second half 2025. Net income excluding extra items shifted from CHF 57m to CHF 3m and then to zero over the same periods, setting up a story where wafer...

Yiren Digital’s FY 2025 Results Put Margins Under the Microscope Yiren Digital (NYSE:YRD) has just closed out FY 2025 with fourth quarter revenue of C¥957.6 million and a loss per share of C¥10.12, as net income excluding extra items came in at a loss of C¥882.2 million against a C¥2.03 share price. The company has seen quarterly revenue range from C¥1,652.1 million in Q2 2025 to C¥1,452.2 million in Q4 2024. Basic EPS moved from a profit of C¥3.84 in Q4 2024 to a loss in the latest quarter,...

Almonty Industries FY 2025 earnings snapshot Almonty Industries (TSX:AII) has put out a tough FY 2025 first half, with revenue of CA$15.1 million and a basic EPS loss of CA$0.49 alongside a net loss of CA$92.8 million, keeping profitability firmly in the red. The company has seen revenue move from CA$15.8 million and EPS of CA$0.03 loss in 1H 2024 to CA$13.1 million and EPS of CA$0.06 loss in 2H 2024, and now to CA$15.1 million with a materially deeper EPS loss in 1H 2025. The latest print...

Hyperfine (HYPR) closed out FY 2025 with Q4 revenue of US$5.3 million and a net loss of US$5.9 million, equal to a basic EPS loss of US$0.06. On a trailing twelve month basis it generated US$13.6 million of revenue and a total net loss of US$35.6 million, or a basic EPS loss of US$0.43. Over the past four reported quarters, revenue has moved from US$2.1 million in Q1 2025 to US$5.3 million in Q4 2025, while quarterly basic EPS losses ranged between US$0.06 and US$0.14 per share. This keeps...

One Stop Systems (OSS) has put up a mixed FY 2025 scorecard so far, with Q3 revenue of about US$18.8 million and basic EPS of roughly US$0.01, alongside trailing 12 month revenue of about US$60.3 million and a loss of roughly US$6.9 million on a basic EPS basis of about US$0.32. The company has seen quarterly revenue move from about US$13.2 million in Q2 2024 to US$15.1 million in Q4 2024, then to US$12.3 million in Q1 2025, US$14.1 million in Q2 2025 and US$18.8 million in Q3 2025. Basic EPS...

WELL Health Technologies (TSX:WELL) has wrapped up FY 2025 with fourth quarter revenue of C$384.8 million and basic EPS of C$0.09, alongside net income of C$22.9 million, putting hard numbers around a year where the business stayed loss making on a trailing twelve month basis. Over the last six reported quarters, revenue has moved from C$193.2 million in Q4 2024 to C$384.8 million in Q4 2025, while basic EPS has ranged from a loss of C$0.36 in Q3 2024 to a profit of C$0.09 in the latest...

Premium Brands Holdings (TSX:PBH) has wrapped up FY 2025 with fourth quarter revenue of C$1.9b and basic EPS of C$0.26, alongside trailing twelve month revenue of C$7.5b and EPS of C$0.91 that sit against a current share price of C$87.05. The company has seen quarterly revenue move from C$1.64b and EPS of C$0.84 in Q4 2024 to C$1.9b and C$0.26 in Q4 2025, with trailing net profit margins compressing from 1.9% to 0.5% as the key tension point for investors weighing growth expectations against...

Vitalhub (TSX:VHI) closed out FY 2025 with Q4 revenue of C$31.4 million and basic EPS of C$0.06, framing a year where trailing twelve month revenue reached C$109.0 million and EPS came in at C$0.10 alongside net income of C$6.1 million. The company has seen quarterly revenue move from C$20.6 million and EPS of C$0.02 in Q4 FY 2024 to a mix of positive and loss-making quarters through FY 2025. This culminated in Q4 EPS of C$0.06 that sits against a trailing net margin of 5.6% and a one-off...

Wondering if Stagwell at around US$6.21 is offering value or just noise in your portfolio? This article breaks down what that price could really mean for you. Over the last month the share price is up 31.0%, after a 1.0% decline over the past week, with a 31.3% return year to date and 1.8% over the past year setting the recent context. Recent coverage around Stagwell has focused on its position within the media sector and how investors are weighing its execution against peers. This backdrop...

Satellogic (NasdaqCM:SATL) closed out FY 2025 with Q4 revenue of US$6.2 million and basic EPS of US$0.23, alongside trailing twelve month revenue of US$17.7 million and a trailing EPS loss of US$0.04. Over recent quarters the company has seen revenue move from US$3.4 million in Q1 2025 to US$6.2 million in Q4 2025, while quarterly EPS ranged from a loss of US$0.34 in Q1 2025 to a profit of US$0.23 in Q4 2025. This sets up a results season where investors are likely to focus on how durable any...

Versamet Royalties (TSX:VMET) has drawn fresh attention after reporting full year 2025 results, alongside its addition to the NASDAQ Composite Index. This gives investors new context for assessing this metals royalty and streaming business. See our latest analysis for Versamet Royalties. The recent earnings release and NASDAQ Composite inclusion have come alongside a 9.72% 90 day share price return and a 5.42% 30 day share price return, suggesting momentum has been building despite a softer 1...

4D Molecular Therapeutics (FDMT) closed out FY 2025 with Q4 revenue of US$85.1 million and basic EPS of US$0.30, a sharp contrast to the prior quarter when revenue was US$0.09 million and EPS was a loss of US$1.01. Over the past few quarters, revenue has moved from US$0.001 million in Q4 2024 to US$0.09 million in Q3 2025 and then to US$85.1 million in Q4 2025, while EPS has shifted from a loss of US$0.89 to a loss of US$1.01 before turning to a positive US$0.30. This sets up a story where...

Aebi Schmidt Holding (NasdaqGS:AEBI) has just posted its FY 2025 numbers with fourth quarter revenue of US$528.4 million and basic EPS of US$0.11, alongside trailing twelve month revenue of about US$1.5 billion and EPS of US$0.17. The company has seen quarterly revenue move from US$262.5 million and EPS of US$0.11 in Q3 2024 to US$471.3 million and EPS of US$0.02 in Q3 2025, before reaching the latest Q4 2025 outcome. This sets up a results season in which investors will be weighing top line...